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Biomer/poly(N-isopropylacrylamide)/[poly(NiPAAm)] ther- 
mosensitive polymer blends were prepared and their ap- 
plication as heparin-releasing polymer coatings for the pre- 
vention of surface-induced thrombosis was examined. The 
advantage of using poly(NiPAAm)-based coatings as hep- 
arin-releasing polymers is based on the unique tempera- 
ture-dependent swelling of these materials. At room tem- 
perature, i.e., below the lower critical solution temperature 
(LCST) of poly(NiPAAm), the Biomer/(poly(NiPAAm) coat- 
ings are highly swollen. The high swelling enables fast 
loading of hydrophilic macromolecules (e.g., heparin) into 
the coating by a solution sorption technique. At a body 
temperature, i.e., above the LCST of poly(NiPAAm) the 
coatings are in a deswollen state and the absorbed macro- 
molecules may be slowly released from a dense coating via 
a diffusion controlled mechanism. Biomer/poly(NiPAAm) 
coatings were obtained by blending and coprecipitation of 
the two linear polymers, Biomer and (poly(NiPAAm). The 
structure and water-swelling properties of the coatings 
were examined. Significant differences in water swelling at 
room temperature (RT) and 37°C were observed as a result 
of the thermosensitivity of poly(NiPAAm). The surface 
structure of the coatings in dry and swollen states at RT and 
37°C was examined by scanning electron microscopy. Hep- 
arin was loaded into the coatings via a solution sorption at 
room temperature. Kinetic studies of heparin loading dem- 
onstrated that maximum loading was obtained within 1 h. 
The in vitro (37°C) release profiles were characterized by a 
rapid initial release due to the squeezing effect of the col- 
lapsing polymer network, followed by a slower release 
phase controlled by heparin diffusion through the dense 
coating. The short-term antithrombogenicity of intravenous 
polyurethane catheters coated with heparin-releasing Bi- 
omer/poly(NiPAAm) thermosensitive coating was evalu- 
ated in a canine animal model. The results show that the 
heparin release from Biomer/poly(NiPAAm)-coated sur- 
faces resulted in a significant reduction of thrombus forma- 
tion on test surfaces in contact with venous blood as com- 
pared to control surfaces. 0 1995 John Wiley & Sons, Inc. 
INTRODUCTION 
Recently, pharmaceutic approaches have been sug- 
gested as the most effective methods to obtain blood- 
compatible  materials. '  Such pharmaceut ic  ap- 
proaches include the use of materials in  which anti- 
coagulant and/or antiplatelet drugs are incorporated 
along with the polymer. Drugs which have been 
studied include heparin,24 prostaglandins,' uroki- 
nase,6 heparin-pr~staglandin,~ and  heparin-albumin 
conjugates.8 Therapeutically, high concentrations of 
anticoagulant and/or antiplatelet agents present at 
the blood-polymer interface may be advantageous 
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partment for Pharmaceutics and Pharmaceutical Chemistry 
and Center for Controlled Chemical Delivery, University of 
Utah, 421 Wakara Way #318, Salt Lake City, UT 84108. 
over systemic anticoagulation for patients using car- 
diovascular devices. With localized drug action, con- 
centrations exceeding those tolerable at the systemic 
level could be applied, and side-effects such as hem- 
orrhage and  thrombocytopenia associated with sys- 
temic administration can be minimized.' 
Heparinization of polymers for the design of blood- 
compatible surfaces has  developed as  heparin-re- 
leasing and heparin-immobilized systems"; the focus 
of this article is a heparin-releasing system. To date, 
two main approaches to heparin-releasing systems 
have been pursued: heparin ionically bound onto 
positively charged  surface^,^,^'-'' and  heparin dis- 
persed within hydrophobic polymeric rnatr ice~. '~ ' '  
Ionically bound heparin is released into the blood by 
an ion-exchange mechanism, leaving a positively 
charged surface which may adversely interact with 
platelets. 
Journal of Biomedical Materials Research, Vol. 29, 811-821 (1995) 
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Heparin could be dispersed within the hydropho- 
bic polymeric matrix and either cast to form a bulk 
material16 or applied as a coating on the surface of 
another polymer substrate. 17,18 Dispersed heparin is 
released from the polymeric matrix by a diffusion 
mechanism. Arterial grafts, fabricated using silicone 
rubber or silicone rubber-graphite containing dis- 
persed heparin, demonstrated diminished thrombus 
formation for 2 h.16 Heymann et a1.I8 described 
heparin-releasing polyurethane coatings prepared 
using a dip-coating technique. Polyurethane cathe- 
ters were coated with a polyurethane solution con- 
taining a heparin dispersion in dimethyl acetamide. 
Application of this method of coating resulted in 
heparin-releasing polyurethane catheters that exhib- 
ited a significant reduction in thrombus formation af- 
ter 1 h of exposure to canine blood. Using polyester- 
polyurethanes (PEO-SPU), Lin et al.17 obtained poly- 
urethane coatings containing dispersed heparin by 
coating the inner lumens of PEO-SPU tubes with a 
PEO-SPU-heparin solution in dimethyl formamide. 
This coating technique involved an initial dissolution 
of heparin in formamide. A heparin release rate of 
0.24 p,g/cm2/h from the coating was needed to main- 
tain the patency of a rabbit arterio-arterial shunt for 5 
h. A controlled-release heparin surface was also fab- 
ricated from poly(hydroxyethylmethacrylate), with 
heparin release from the monolithic device lasting 10 
h.19 More recent studies demonstrated the possibility 
of heparin release from an electroerodible polyelec- 
trolyte complex for a pulsatile heparin release system. 
An insoluble polyelectrolyte complex was formed by 
combining two water-soluble polymers, poly(a1- 
lylamine) and heparin. Upon the application of an 
electric current, a rapid structural change of the com- 
plex caused the dissolution of polymer matrix and 
subsequent heparin release in the amount propor- 
tional to the applied current.20 
In this report we describe a novel thermosensitive 
heparin-releasing polymer coating for the prevention 
of surface-induced thrombosis. The thermosensitive 
coating was fabricated by blending and coprecipita- 
tion of two linear polymers: Biomer and poly- 
(NiPAAm). Biomer is a multiple block copolyether- 
urethane-urea which has been used for biomaterial 
application by numerous investigators, and demon- 
strated to have acceptable mechanical and biologic 
properties.21 As a hydrophobic polymer, Biomer is 
expected to enhance the mechanical properties of the 
coating and also to improve binding between the gel 
coating and a hydrophobic polyurethane substrate. 
Poly(NiPAAm) is a thermosensitive polymer with a 
lower critical solution temperature (LCST) in aqueous 
solutions of around 32"C.22 LCST results from tem- 
perature dependence of polymer-water and poly- 
mer-polymer interactions leading to a coil-globule 
transition of polymer chains. As a result of this tran- 
sition, gels composed of crosslinked poly(NiPAAm) 
demonstrate decreased swelling levels with increas- 
ing temperatures, and deswell dramatically at tem- 
peratures close to the LCST. This so-called negative 
thermosensitivity implies many possible applications 
of poly(NiPAAm)-based thermosensitive hydrogels 
in controlled drug d e l i ~ e r y ~ ~ , ~ *  and molecular sepa- 
ration p r o c e s s e ~ . ~ ~ , ~ ~  
The rationale of using Biomer/poly(NiPAAm) 
thermosensitive coatings as heparin-releasing poly- 
mers is the following: When immersed into a heparin 
loading solution at low temperature a thermosensi- 
tive coating exhibiting negative thermosensitivity 
would swell and absorb the drug. At higher (body) 
temperature, the swollen coating would collapse and 
release heparin (Fig. 1). An initial rapid release of 
heparin due to the squeezing effect of the collapsing 
polymer would be expected to be followed by a slow 
release of drug controlled by solute diffusion within 
the collapsed network. 
A significant advantage of the thermosensitive hy- 
drogel coating is the possibility of solution sorption 
loading of relatively large amounts of drugs, such as 
proteins and heparin, which demonstrate limited sol- 
ubility in organic solvents. This simple solution sorp- 
tion loading procedure, using the thermosensitivity 
of Biomer/poly(NiPAAm) coatings, is advantageous 
over procedures that involve the use of organic sol- 
vents which may affect the bioactivity of the loaded 
drugs. Also, compared to other heparin-releasing 
polymers, this system offers flexibility as to the 
amount and type of anticoagulant drug(s) which can 
be loaded into the thermosensitive coating. Different 
anticoagulant and antiplatelet agents, including 
drugs with short-term stability (e.g., prostacycline), 
could be loaded from the same loading solution into 
the coated device (e.g., catheter) directly before use. 
This article describes the preparation and charac- 
terization of Biomer/poly(NiPAAm) thermosensitive 
coatings as heparin-releasing polymers for the pre- 
vention of surface-induced thrombosis. Surface mor- 
phology of coated catheters was studied using scan- 
Room temperature Body temperature 
Coatingswdkand 
atsorhs heparin from 
loading solution 
coating &swells and 
releases hepann 
Figure 1. Biomer/poly(NiPAAm) thermosensitive coat- 
ings as heparin-releasing polymers. 
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ning electron microscopy (SEM). Loading and in vitro 
release kinetics of heparin from coated catheters was 
also investigated. The effect of such coatings on 
blood-material interactions was examined in vivo in a 
canine model. 
EXPERIMENTAL 
Materials 
N-isopropylacrylamide (NiPAAm) and 2,2'-azobis- 
izobutyronitrile (AIBN) obtained from Eastman 
Kodak Company (Rochester, NY), were recrystallized 
from hexane and methanol, respectively. Benzene, 
HPLC grade, and N,N-dimethylacetamide (DMAc), 
glass-distilled spectral grade were obtained from Al- 
drich Chemical Company (Milwaukee, WI) and used 
as received. Solution-grade Biomer (copolyether- 
urethane-urea) was purchased from Ethicon (Sum- 
merville, NJ) as a 25% solution in DMAc and precip- 
itated twice in methanol, vacuum dried, and stored at 
20°C. Biomer solutions were prepared as 10 wt % of 
polymer in DMAc prior to coating. Heparin sodium 
USP from porcine intestinal mucosa, 201.4 USP 
U/mg, was purchased from Diosynth (Chicago, IL). 
Polyurethane intravenous catheters (Vialon@; 1.3 mm 
OD) were obtained from Becton Dickinson Vascular 
Access (Salt Lake City, UT). Freshly prepared Kar- 
novsky solutionz7 was used as a fixative. Phosphate- 
buffered saline solution (PBS), containing 0.01M 
phosphate, pH = 7.4, was used as a medium in all in 
vitro studies. 
METHODS 
Synthesis of poly(NiPAAm) 
Poly(NiPAAm) was synthesized using free-radical 
polymerization. The reaction was carried out in ben- 
zene using AIBN as an initiator.28 A solution of 
NiPAAm (10 g) and AIBN (1 mol %) in benzene (80 
mL) was degassed under vacuum and stirred for 20 h 
at 50°C under a nitrogen atmosphere. After polymer- 
ization the solvent was evaporated and the remaining 
solute was dissolved in acetone (100 mL) and precip- 
itated into a 10-fold excess of hexane. After filtering 
and drying, 8.7 g of polymer was obtained (87% 
yield). 
Synthesized poly(NiPAAm) was characterized us- 
ing IR spectroscopy and gel permeation chromatog- 
raphy (GPC). The IR spectrum of the polymer did not 
contain the following bands usually observed in the 
spectrum of monomer: 1620 cm (C=C), 1401 cm 
(CH), and C-H vinyl out of plane bending vibra- 
tions.28 This suggested that the unreacted monomer 
content was below the detection limit of the IR spec- 
troscopy (i.e., below 1%). The molecular weight of 
the polymer estimated by GPC, based on polystyrene 
standards,28 was in the range of 280 Kd with a poly- 
dispersity index, M J M N  = 1.75. GPC analysis also 
confirmed the high purity of the polymer sample. 
LCST of the polymer in PBS solution was deter- 
mined by cloud point measurements using UV spec- 
troscopy (450 nm).28 An abrupt increase in absor- 
bance (cloud point) corresponding to the LCST was 
observed at 32°C. 
Coating procedure 
Polyurethane intravenous catheters (Vialon@) were 
coated with a 10 wt % Biomer/poly(NiPAAm) solution 
in DMAc, using a dip-coating technique followed by 
the coprecipitation of Biomer and poly(NiPAAm) in 
hot water (the nonsolvent for both polymers). To ob- 
tain reproducible and even coatings, polyurethane 
catheters were immersed in and removed from the 
coating solution at the same rate. Catheters were kept 
in a vertical position throughout the coating proce- 
dure. Compositions of the coating solutions are sum- 
marized in Table I. Each Biomer/poly(NiPAAm) solu- 
tion layer was precipitated in water at 50°C for 1 h 
and air dried for 0.5 h. Coating and precipitation pro- 
TABLE I 
Composition and Properties of Biomer/Poly(NiPAAm) Coating Solutions 
Solubility of Coating Solution Composition (wt %) 
Solution Biomer Poly(NiPAAm) DMAc Components Phase Separation 
B 10.0 90 Soluble No phase separation 
B/N (1:l) 5.0 5.0 90 SolubIe Phase sep. in 5 min 
B12N (12) 3.3 6.6 90 Soluble Phase sep. in 10 h 
B13N (1:3) 2.5 7.5 90 Soluble Phase sep. in 3 h 
N 10.0 90 Soluble No phase separation 
B, Biomer; N, poly(NiPAAm). 
814 GUTOWSKA ET AL. 
cedures were repeated four times to obtain a 0.3-mm- 
thick coating. 
Water-swelling properties 
Water-swelling properties of Biomeripoly- 
(NiPAAm) thermosensitive coatings were studied at 
room temperature and 37°C. The room temperature 
water content was determined after swelling of 
coated catheters in PBS for 1 h.  At longer times (after 
2 h) slow dissolution of poly(NiPAAm) from the 
blend matrix was observed. The dissolution of poly- 
(NiPAAm) was monitored by measuring the absor- 
bance of the swelling medium at 450 nm. A small 
sample of the swelling medium was incubated at 37°C 
(above the cloud point), and its absorbance was com- 
pared to the absorbance of pure water. 
The equilibrium water content at 37°C was deter- 
mined after swelling in PBS for 3 days. Water percent 
in the coating was calculated as 
W% = (W, - W,)/(W, - W,) x 100% 
where W, denotes the weight of catheter swollen in 
PBS, W, denotes the weight of a dry-coated catheter, 
and W, denotes the weight of the catheter before 
coating. 
Heparin loading 
Directly before use, catheters with Biomeri 
poly(NiPAAm) thermosensitive coatings in a dry 
state were immersed in 5 wt 72 heparin loading solu- 
tion (PBS) at RT. After loading for 1 h, catheters were 
rinsed briefly in PBS, air dried for 20 min, and used 
immediately. This loading procedure was applied for 
both in vitra and in vivo studies. The total amount of 
loaded drug was determined after extensive extrac- 
tion in buffer solution at RT using the Azure I1 color- 
imetric assay.29 In this assay the absorption of hepa- 
rin-Azure I1 complex was measured at 500 nm. Sam- 
ples (0.5 ml) of the release medium were added to 4.5 
mL of 0.01 mg/mL Azure I1 solution in water and 
vigorously mixed on the Vortex mixer. Absorption of 
the solution was measured after 1 min, with water 
used as a reference. 
Loading percent in the coated polymer layer was 
calculated as 
Load% = {Wdrug/(Wpolymer + wdrug)> loo 
where W d r u g  denotes the weight of heparin and 
Wpolymer denotes the weight of the dry polymer coat- 
ing. 
In vitro heparin release 
The in vitro heparin release from coated catheters 
was conducted at 37°C in PBS at pH 7.4. To maintain 
sink conditions, catheters were transferred at prede- 
termined times into 10 mL of fresh PBS preequilibrat- 
ed at 37°C. The amount of released heparin was mea- 
sured by the Azure I1 colorimetric assay.29 Calcula- 
tions of release rates, expressed in Fg/cm2 per h, were 
based on the dimensions of catheters at 37°C. 
In vivo experiments 
Surgical protocol 
Mongrel dogs (20-30 kg) were used for the in vivo 
experiments. NIH guidelines for the care and use of 
laboratory animals (NIH Publication no. 85-23, Rev. 
1985) were observed, and the procedure was ap- 
proved by the Institutional Animal Care and Use 
Committee, University of Utah. Dogs were preanes- 
thetized with Biotol, anesthetized with Halothane, 
and mechanically ventilated. Intravenous catheters 
with a thermosensitive Biomer/poly(NiPAAm) coat- 
ing and control polyurethane catheters (18 GA, 2 in.) 
were inserted percutaneously into front and hind 
contralateral saphenous veins and kept in place for 
1.5 h. The vessels were then exposed and ligated both 
proximal and distal to the catheter site; all branches 
were tied off. The entire vein and catheter was re- 
moved and placed in fresh saline. The anesthetized 
animals were then euthanized intravenously with 
Beuthanasia. During the experiment, blood samples 
were withdrawn to measure activated partial throm- 
boplastin times (APTT)30 to evaluate the systemic ef- 
fect of the released heparin. 
Examination of catheters surface after in 
vivo experiments 
Macroscopic evaluation 
Vessels with the catheters in place were opened 
longitudinally for gross examination and photo- 
graphed. Catheters were then placed in the fixative 
solution for subsequent processing and evaluation 
under the scanning electron microscope (SEM). 
Scanning electron microscopic evaluation 
Following 3 days of exposure to fresh fixative so- 
lution at 37"C, catheters were rinsed and transferred 
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to a saline solution containing 0.02% sodium azide. 
Representative catheter sections were selected for 
SEM examination. Samples were rinsed in distilled 
water to remove the saline solution, freeze dried, 
coated with gold (Technics Sputter Coaster; Hummer 
111, Alexandria, VA), and examined with an SEM 
(JEOL JSM-35; JEOL USA, Peabody, MA) at 15-25 KV 
accelerating voltage. Surfaces with and without ad- 
herent thrombus were examined and photographed 
at magnifications ranging from x 10 to X 1200. Coated 
catheters that were not exposed to blood were also 
examined in the same way. 
RESULTS AND DISCUSSION 
Properties of Biomer/poly(NiPAAm) 
thermosensitive coatings 
The blending of hydrophilic and hydrophobic poly- 
mers produces a phase-separated composite hydro- 
gel.31 A solvent-casting technique is the most com- 
mon method used to blend polymers. In this process, 
the polymers to be blended are dissolved in a com- 
mon solvent and a desired form is cast. The polymer 
blend is obtained after the removal of solvent. The 
-kCH::  - fH 3 
c = o  
I 
NH 
resulting materials are often opaque as a result of the 
phase-separated structure. 
This blending technique was used in this study to 
obtain Biomer/poly(NiPAAm) thermosensitive coat- 
ings (Fig. 2). Biomer is a hydrophobic, multiple-block 
copolyether-urethane-urea with acceptable biocom- 
patibility and good mechanical properties. Poly- 
(NiPAAm) is a thermosensitive polymer demonstrat- 
ing a lower critical solution temperature in aqueous 
solutions. Hence, the resulting polymer blend will 
likely have the properties enhanced by the qualities 
of both polymers, the thermosensitivity of p l y -  
(NiPAAm) and the mechanical strength of Biomer. 
Figure 2 illustrates the schematics of blending pro- 
cedure and the chemical structure of components: the 
repeating monomer unit in poly(NiPAAm) polymer 
and the Biomer structure. Solution-grade Biomer, as 
determined by Lelah et a1.21 consists of poly(tetra- 
methylene oxide) soft segments and hard segments 
identified as 4,4’-diphenylmethanediisocyanate, 
chain extended with diamines. Biomer as a hydro- 
phobic polymer precipitates in water. At tempera- 
tures above the LCST (i.e., 32°C) the poly(NiPAAm) 
undergoes a coil-globule transition and also precipi- 
tates in aqueous solutions.32 
Biomer/poly(NiPAAm)-coating solutions were pre- 
pared as a 10 wt % polymer solution in DMAC, a com- 
pol y (Ni P AAm) 
I 
CH 
CH3’ ‘CH3 
+ 
Biomer 
Blending i n  DMAc 
Precipitation i n  water (50°C) 
Network-like structure of 
Blomer/pol y(NiPAAm) 
thermosensitive coating 
:‘ : 
Figure 2. 
Biomer/poly(NiPAAm) polymer blend. 
Schematic diagram showing components used for the synthesis and the resulting networklike structure of 
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mon solvent for both polymers. Compositions of the 
coating solutions are listed in Table I. Polymers were 
readily soluble at the concentrations used; however, 
some phase separation was observed. Compatibility 
of the components on a molecular level is often a 
problem in the preparation of stable polymer solu- 
tions. The phase separation, often observed in solu- 
tions containing two different polymers, is due to 
long-chain polymer-polymer incompatibility, result- 
ing from the negligible gain in the entropy of mix- 
ing.33 A solution containing equal amounts of Biomer 
and poly(NiPAAm) exhibited almost immediate and 
extensive phase separation, and thus was not suitable 
for coating. In the case of B/2N and B/3N solutions, 
containing 1:2 and 1:3 ratios of Biomer and poly- 
(NiPAAm), respectively, the phase separation was 
observed only after 10 and 3 h, respectively (Table I). 
Hence, freshly prepared B/2N and B/3N solutions ex- 
hibited sufficient stability to be used for the coating 
procedure. 
Intravenous polyurethane catheters (Vialon@) were 
coated with Biomer, poly(NiPAAm), and Biomeri 
poly(NiPAAm) thermosensitive coatings, BI2N and 
B/3N. The dip-coating of catheters was followed by 
precipitation of the coated layer in hot water (50"C), a 
nonsolvent for both polymers. Simultaneous precip- 
itation of Biomer and poly(NiPAAm) resulted in en- 
tanglement of polymer chains; therefore, Biomer 
prevented immediate dissolution of poly(NiPAAm) 
at temperatures below the LCST. Biomer/poly- 
(NiPAAm) coatings exhibited a networklike struc- 
ture and did not readily disintegrate in aqueous so- 
lutions at room temperature. In contrast, the coating 
containing only poly(NiPAAm) starts to dissolve 
within minutes of the contact with water at room 
temperature. All coatings were very stable at 37°C; at 
this temperature, water is a nonsolvent for both poly- 
mers. 
Table I1 summarizes the properties of Biomer/ 
poly(NiPAAm) thermosensitive coatings. The room 
temperature water content was determined after 
swelling in PBS for 1 h. After this time, slow leaching 
of poly(NiPAAm) from B/3N coating into the buffer 
was observed. Poly(NiPAAm) is soluble in aqueous 
solutions at temperatures below the LCST (i.e., 32°C). 
The B/2N coating, containing less poly(NiPAAm), 
was more stable in PBS at RT, and leaching was ob- 
served after 3 h of swelling. A slow dissolution of 
poly(NiPAAm) was observed only at temperatures 
below the LCST. Since the coatings were stable at 
37°C [i.e., above the LCST of poly(NiPAAm1, it was 
possible to determine the equilibrium water content 
at this raised temperature after 3 days of swelling. 
Surface morphology of the bare and coated cathe- 
ters was evaluated using SEM. The surface of the 
control polyurethane catheter shown in Figure 3A 
was relatively smooth, with some extrusion marks 
clearly visible at this magnification. Figure 3B illus- 
trates the surface of the B/2N coating in a dry state, at 
the same magnification as Figure 3A. Although the 
surface of the dry coating was rougher, the difference 
in the fabrication procedure should be taken into ac- 
count: the coating was obtained by coagulation and 
the polyurethane catheter was extruded. 
Figure 3C shows the freeze-dried surface of the B/2N 
coating swollen at RT, while Figure 3D shows the 
same material deswollen at 37°C. The Bi2N coating 
swollen at RT contained about 50% water, and the 
surface of the coating appeared porous after freeze 
drying. In a deswollen state at 37"C, the coating con- 
tained about 15% water and exhibited a dense, rough 
surface. 
Heparin loading and release in vitro 
Coated, dried catheters were immersed in the hep- 
arin loading solution at RT and the kinetics of heparin 
loading was examined. The results presented in Fig- 
ure 4 indicate that maximum loading was attained 
after 1 h. The amount of heparin in the coatings was 
determined after an extensive RT extraction of loaded 
catheters with the loading percent calculated from the 
weight of dry coating. The maximum heparin loading 
in B/2N was 1.5 2 0.3% and in B/3N coating, 2.0 k 
0.4% (n  = 4) (Table 11). The higher heparin loading 
percent in B/3N coating was related to the increased 
TABLE I1 
Properties of Biomer/Poly(NiPAAm) Thermosensitive Coatings 
Thickness (mm) 
Water % at Water % at Swollen, Swollen, Heparin Load 
Coating Room Temp. 37°C Dry Room Temp. 37°C % 
B 0.25 t 0.05 0.65 ? 0.08 0.25 t 0.03 0.25 2 0.03 0.25 ? 0.03 0.0 
B/2N (12) 50.7 t 2.3 15.4 ? 1.4 0.25 r+ 0.03 0.55 ? 0.03* 0.35 ? 0.03 1.5 t 0.3 
2.0 t 0.4 B/3N (1:3) 71.3 * 4.5 16.3 t 1.2 0.25 ? 0.03 0.65 ? 0.03* 0.35 t 0.03 
N Dissolves 15.9 ? 1.7 0.21 t 0.03 Dissolves 0.30 -t 0.03 Not loaded 
B, Biomer; N, poly(NiPAAm). 
*Measured after 1 h (at longer times, slow leaching of poly(N1PAAm) from coatings was observed at room temperature). 
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Figure 3. Scanning electron micrographs of the polyure- 
thane catheter and Biomer/poly(NiPAAm) thermosensitive 
material coated on the polyurethane catheter. (A) Control 
polyurethane catheter ( ~ 4 7  magnification); (B) BRN coat- 
ing in a dry state ( ~ 4 7 ) ;  (C) BRN coating swollen at room 
temperature (x50); (D) BI2N coating swollen at 37°C ( ~ 3 3 ) .  
swelling resulting from the higher poly(NiPAAm) 
content in the BI3N polymer blend. 
For in vitro heparin release studies, catheters with 
Bl2N and Bl3N coatings were loaded with heparin at 
RT for 1 h, air dried for 20 min, and immersed in PBS 
at 37°C. Heparin release profiles presented in Figure 
5 indicate that 70% of the total heparin content was 
released within the first 15 min and the remaining 
amount was released with a slower rate for 6 h. The 
initial rapid heparin release was related to the squeez- 
Time [min] 
Figure 4. 
poly(NiPAAm) thermosensitive coatings. 
The kinetics of heparin loading into Biomeri 
1 .o 
0.8 
0.6 
0.4 
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0.0 4 I I I 
0 6 0  120 1 8 0  240 
Time [min] 
Figure 5. 
(NiPAAm) thermosensitive coatings. 
In vitro heparin release from Biomeripoly- 
ing action of the collapsing polymer network, and the 
following slow release was controlled by heparin dif- 
fusion through the collapsed matrix. Considering the 
thickness of the BiomerIpoly(NiPAAm) coatings in a 
collapsed state at 37°C (Table 11), the total heparin 
content could diffuse out in a relatively short time. 
However, solute diffusion was decreased within the 
collapsed network. 
Heparin release rates, presented in Figure 6, were 
calculated for the BI2N coating, based on catheter di- 
mensions at 37°C. The initial squeezing of heparin 
from the collapsing thermosensitive coating resulted 
in an initial rate above 100 pgih per cm2. The subse- 
quent slower release, controlled by heparin diffusion 
within the collapsed matrix, resulted in a release rate 
above 1.0 pgih per cm2 for about 6 h. This release rate 
was above the minimum heparin release rate re- 
quired to maintain the nonthrombogenicity of a poly- 
urethane surface, as determined by Lin et al.I7 In 
their studies, a minimum critical heparin release rate 
of 0.24 pglh per cm2 was needed to maintain a throm- 
bus-free polymer-blood interface in a rabbit arterio- 
arterial shunt model. 
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Figure 6. Heparin release rate from Biomer/poly(NiPAAm) 
thermosensitive coating (BRN); calculated based on the 
catheter dimensions at 37°C. 
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Figure 7. Gross view of tested and control catheters after in v im contact with dog venous blood for 1.5 h. (A) Catheter with 
heparin-releasing Biomerlpoly(NiPAAm) thermosensitive coating, surface free of adherent blood elements; (B) control 
polyurethane with associated thrombus. 
The BIZN and BI3N coatings demonstrated compa- 
rable heparin release rates; however, the superior 
mechanical properties of BI2N coating in swollen 
state suggested the use of this coating for in vim 
studies. 
IN VlVO STUDIES 
The initial events occurring on the blood-contacting 
surface are important in controlling surface-induced 
thrombosis. These events include the immediate 
adsorption of a protein layer and the subsequent ac- 
tivation of the intrinsic clotting pathway. If not pre- 
vented, thrombosis occurs within minutes upon the 
contact of blood with a polymer surface. Initially high 
local concentrations of heparin released from Biomeri 
poly(NiPAAm) at the blood-contacting surface would 
prevent clotting, and the subsequent slow release of 
heparin would further deter the surface-induced 
thrombosis. 
The short-term in v im blood compatibility of a hep- 
arin Biomer’poly(NiPAAm) thermosen- 
sitive coating was in a canine ‘On- 
trol polyurethane catheters and catheters with hepa- 
rin-releasing BiZN thermosensitive coating were 
inserted in to the saphenous veins of dog for 1.5 h. 
Saphenous veins were selected because of their size 
and the fact that ’lower flow and reduced pul- 
Satility Creates a relatively more thrombogenic enVi- 
ronment. 
Figure 8. Scanning electron micrographs of catheters from 
Figure 7: the control polyurethane catheter and the catheter 
with heparin-releasing Biomer/poly(NiPAAm) thermosen- 
sitive coating. (A) Control polyurethane catheter with the 
adherent thrombus (same catheter as in Fig. 7B) (X34); (B) 
Higher magnification of the thrombus, with the fibrin net- 
work and cellular blood elements clearly visible (~1100) ;  (C) 
Surface of B/2N coating, fibrin network and blood elements 
not visible (same catheter as in Fig, 7A) ( ~ 2 2 ) ;  (D) Higher 
magnification of the clean surface of BRN coating (~100). 
HEPARIN FROM THERMOSENSITIVE POLYMER COATING 819 
Figure 9. Gross view of the catheter with control Biomer/poly(NiPAAm) thermosensitive coating containing no heparin, 
after in vivo contact with dog venous blood for 1 .5  h. (A) Catheter with thrombus visible on the distal end; (B) the underside 
of the catheter from (A). 
Following a 1.5-h exposure to venous blood, ves- 
sels and catheters were removed and placed in fresh 
saline. Vessels were then opened longitudinally for 
gross examination, and photographs of exposed cath- 
eters with associated thrombus were taken. A repre- 
sentative picture of the catheter with heparin releas- 
ing Biomer/poly(NiPAAm) thermosensitive coating 
(BI2N coating) after exposure to dog venous blood is 
presented in Figure 7A. After 1.5 h exposure to ve- 
nous blood, catheters with heparin-releasing B/2N 
coating showed mostly clean surfaces, with some fi- 
brin network formation but no massive thrombi. Two 
of five examined catheters exhibited a small thrombus 
adherent to the surface, but the vein surface re- 
mained thrombus free. It was suggested that, as a 
result of the relatively weak mechanical properties of 
the coating in a swollen state, some damage of the 
coating may have occurred during the percutaneous 
insertion of the coated catheter. As shown in Figure 
TB, the control polyurethane catheter also demon- 
strated thrombus formation during in vivo contact 
with dog venous blood. 
Scanning electron micrographs of catheters from 
Figure 7 are presented in Figure 8. A control polyure- 
thane catheter with adherent thrombi is shown in 
Figure 8A. At higher magnification ( x  1100), fibrin 
networks and cellular blood elements (red blood cells 
and platelets) are clearly visible (Figure 8B). The clean 
surface of the heparin-releasing B/2N coating, with 
no blood elements visible, is shown in Figures 8C and 
8D, suggesting that catheters with heparin releasing 
Biomer/poly(NiPAAm) thermosensitive coating dem- 
onstrated reduced thrombus formation as compared 
to the control polyurethane catheters. 
The blood compatibility of a catheter with Biomer/ 
poly(NiPAAm) thermosensitive coating containing 
no heparin was also examined. Figure 9 shows the 
control B/2N catheter (no heparin) after exposure to 
dog venous blood in vim.  In Figure 9A, the thrombus 
formation on the distal end of the catheter is clearly 
visible. On the underside of the same catheter (hid- 
den from sight in Fig. 9A) thrombus formation ap- 
pears to have started from the middle of the catheter 
(Fig. 9B). SEMs of the above control B/2N catheter (no 
heparin) are presented in Figure 10. Higher magnifi- 
cation of the distal end with the thick layer of adher- 
ent thrombus is shown in Figure 1OB. The structure of 
the thrombus with a dense fibrin network, platelets, 
and red blood cells is presented at high magnifica- 
tion ( ~ 1 2 0 0 )  in Figure 1OC. The results presented in 
Figures 9 and 10 suggested that the Biomer/poly- 
(NiPAAm) coating itself was thrombogenic, and a lo- 
cal high concentration of released heparin was 
needed to create the nonthrombogenic surface. 
820 GUTOWSKA ET AL. 
Figure 10. Scanning electron micrographs of the catheter 
with control Biomer/poly(NiPAAm) thermosensitive coat- 
ing containing no heparin, after in vivo contact with dog 
venous blood for 1.5 h. (A) Gross view of the control B/2N 
catheter (same catheter as in Fig. 8) ( ~ 1 0 ) ;  (B) distal end 
with adherent thrombus ( ~ 2 0 ) ;  (C) high magnification of 
thrombus with fibrin network and cellular blood elements 
clearly visible ( x 1200). 
To ensure that the releasing heparin did not affect 
the systemic coagulation parameters, blood samples 
were taken for activated partial thromboplastin time 
(APTT) tests. Since no changes in APTT were ob- 
served throughout the experiment, it can be con- 
cluded that all heparin effects were due only to a local 
concentration. It is also important to note that within 
the experimental error, the APTT times for all tested 
dogs were very similar. Hence, it can be concluded 
that heparin released from the Biomer/poly(NiPAAm) 
thermosensitive coating prevented surface-induced 
thrombosis. 
CONCLUSIONS 
Biomer/poly(NiPAAm) thermosensitive coatings 
were obtained by blending and coprecipitation of the 
two linear polymers. The simultaneous precipitation 
of Biomer and poly(NiPAAm) resulted in a network- 
like structure of the coating with extensive entangle- 
ment of the two polymers. The entangled structure 
deterred dissolution of poly(NiPAAm) in water solu- 
tions at temperatures below the LCST and allowed 
for room temperature solution sorption loading of 
heparin. 
Commercial polyurethane intravenous catheters 
were coated with Biomer/poly(NiPAAm) thermo- 
sensitive coatings, The coatings displayed significant 
difference in water content at room temperature 
(-15%) and 37°C (-50%), due to the thermosensitiv- 
ity of poly(NiPAAm). Furthermore, studies of hepa- 
rin loading kinetics into Biomer/poly(NiPAAm) 
thermosensitive coatings showed that maximum 
loading was attained within 1 h. Studies of in vitro 
heparin-release kinetics demonstrated release rates of 
1 pg/cm2 per h for up to 6 h. 
Antithrombogenic properties of heparin-releasing 
coated catheters were evaluated following 1.5 h of in 
vivo contact with venous blood. Catheters with hep- 
arin-releasing Biomer/poly(NiPAAm) thermosen- 
sitive coating were compared with the control un- 
coated polyurethane catheters. Heparin-releasing 
coated surfaces demonstrated a significant reduction 
of thrombus formation in contact with venous blood 
as compared to the control polyurethane surface. 
Since no changes in APTT times were observed 
throughout the experiment, it can be concluded that 
heparin released from the thermosensitive coating 
prevented surface-induced thrombosis without sys- 
temic effects. 
These results demonstrate that heparin-releasing 
Biomer/poly(NiPAAm) thermosensitive coatings 
have a potential in short-term prevention of surface- 
induced thrombosis on blood-contacting prosthetic 
devices. 
This work was supported by NIH Grant HL 17623-19. 
References 
1. 
2. 
B. D. Ratner, "The blood compatibility catastrophe," 
1. Biomed. Mater. Res., 27, 283-287 (1993). 
S. W. Kim, C. D. Ebert, J. Y. Lin, and J.  C. McRea, 
"Nonthrombogenic polymers: Pharmaceutical ap- 
proaches," J. ASAIO, 6 ,  7687 (1983). 
M. F. A. Goosen and M. V. Sefton, "Properties of 
heparin-poly(vinylalcoho1) hydrogel coating," 1. 
Biomed. Muter. Res., 17, 359-373 (1983). 
H. Tanzawa, Y. Mori, and N. Harumiya, "Preparation 
and evaluation of a new athrombogenic heparinized 
hydrophilic polymer for use in cardio-vascular sys- 
tems," Trans. Am. SOC. Artif. Intern. Organs, 14, 18% 
194 (1973). 
5. J. C. McRea, C. D. Ebert, and S. W. Kim, "Prosta- 
glandin releasing polymers-stability and efficacy," 
Trans. Amer. SOC. Artif. Int. Organs, 27, 511-519 (1981). 
S. W. Kim, C. D. Ebert, J. C. MacRea, C. Briggs, 
S. M. Byun, and H. P. Kim, "The biological activity of 
antithrombotic agents immobilized on polymer sur- 
faces," Annals NY Acud. Sci., 416, 513-524 (1983). 
H. Jacobs and S. W. Kim, "In vitro bioactivity of syn- 
3. 
4. 
6 .  
7. 
HEPARIN FROM THERMOSENSITIVE POLYMER COATING 821 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
thesized PGE,-heparin conjugate," J. Pkarmacol. Sci., 
W. E. Hennink, S. W. Kim, and J. Feijen, "Inhibition 
of surface induced coagulation by preadsorption of 
albumin-heparin conjugates," J. Biomed. Mater. Res., 
T. E. Warkentin, C. P. Hayward, C. A. Smith, P. M. 
Kelly, and J. G. Kelton, "Heparin-induced thrombo- 
cytopenia," J. Lab. Clin. Med., 120, 371-379 (1992). 
K. D. Park, T. Okano, C. Nojiri, and S. W. Kim, 
"Heparin immobilization onto segmented poly- 
urethaneurea surfaces: Effect of hydrophilic spacers," 
J. Biomed. Mater. Res., 22, 977-987 (1988). 
V. L. Gott, J. D. Whiffen, and R. C. Datton, "Heparin 
bonding on colloidal graphite surfaces," Science, 142, 
1297-1230 (1973). 
R. I. Leininger and C. W. Cooper, "Nonthrombo- 
genic plastic surfaces," Science, 152, 1625-1627 (1968). 
G .  A. Grode, S. J. Anderson, H. M. Grotta, andR. D. 
Falb, "Nonthrombogenic materials via a simple coat- 
ing process," Trans. A m .  SOC. Artif. Intern. Organs, 15, 
F. F. Holland, R. G. Mason, and E. Klein, "Thrombo- 
genicity of heparin bound DEAE cellulose hemodial- 
ysis membranes," J. ASAIO, 1, 24-31 (1978). 
R. Shibuta, M. Tanaka, M. Sisido, and Y. Imanishi, 
"Synthesis of novel polyaminoetherurethaneureas 
and development of antithrombogenic material by 
their chemical modifications," J. Biomed. Mater. Res., 
C. A. Hufnagel, P. W. Conrad, and J. F. Gillespie, 
"Characteristics of materials for intravascular applica- 
tions," Ann.  NY Acad. Sci. 146, 262-266 (1968). 
J. Lin, H. Jacobs, C. Nojiri, T. Okano, andS. W. Kim, 
"Minimum heparin release rate for nonthrombogenic- 
ity," Trans. A m .  SOC. Artif. Intern. Organs, 33, 602-605 
(1987). 
P. W. Heymann, C. S. Cho, J. C. McRea, D. B. Olsen, 
and S. W. Kim, "Heparinized polyurethanes: In vitro 
and in vivo studies," J .  Biomed. Mater. Res., 19,419436 
(1985). 
C. D. Ebert, J .  C. McRea, and S. W. Kim, "Controlled 
release of anthithrombotic agents from polymer ma- 
trices,'' in Controlled Release of Bioactive Materials, J .  
Baker (ed.), Academic Press, New York, 1980, pp. 
75, 172-175 (1986). 
18, 911-922 (1984). 
1-6 (1969). 
20, 971-987 (1986). 
107-119. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
I. C. Kwon, Y. H. Bae, and S. W. Kim, "Heparin re- 
lease from polymer complex," f. Controlled Rel., 30, 
155-159 (1994). 
M. D. Lellah and S. L. Cooper, Polyurethanes in Medi- 
cine, CRC, Boca Raton, Florida, 1986. 
H. G. Schild and D. A. Tirrell, "Microcalorimetric de- 
tection of lower critical solution temperatures in aque- 
ous polymer solutions," f. Phys. Ckem., 94, 43524356 
(1990). 
A. S. Hoffman, "Applications of thermally reversible 
polymers and hydrogels in therapeutics and diagnos- 
tics," I .  Control. Rel., 6,  297-305 (1987). 
T. Okano, Y. H. Bae, and S. W. Kim, "Temperature 
responsive controlled drug delivery," in Pulsed and 
Self-Regulated Drug Delivery, J. Kost (ed.), CRC Press, 
Boca Raton, Florida, 1990, pp. 17-46. 
H. Feil, Y. H. Bae, J.  Feijen, and S. W. Kim, "Molec- 
ular separation by thermosensitive hydrogel mem- 
branes,'' J. Membr. Sci., 64, 283-294 (1991). 
R. F. S. Freitas and E. L. Cussler, "Temperature sen- 
sitive gels as size selective absorbants," Separ. Sci. 
Tecknol., 22, 911-919 (1987). 
M. J .  Karnovsky, "Formaldehyde-glutaraldehyde fix- 
ative of high osmolarity for use in electron micros- 
copy," J. Cell Bid. ,  27, 137-145 (1965). 
H. G. Schild, "Poly(N-isopropylacrylamide): Experi- 
ment, theory and application," Prog. Polym. Sci., 17, 
163-249 (1992). 
S. Lam and R. Silbert, Biochem. Biopkys. Res. Commun., 
69, 57Ck576 (1976). 
B. A. Brown, "Hematology: Principles and Procedures," 
Philadelphia, Lea & Febiger, 1984. 
Y. H. Bae and S. W. Kim, "Hydrogel delivery systems 
based on polymer blends, block co-polymers or inter- 
penetrating networks," Adv.  Drug Delivery Rev., 11, 
E. S. Matsuo and T. Tanaka, "Kinetics of discontinu- 
ous volume phase transition of gels," J. Ckern. Pkys., 
88, 427431 (1988). 
P. J .  Flory, "Thermodynamics of polymer solutions," 
Disc. Faraday SOC., 49, 7-29 (1970). 
109-135 (1993). 
Received June 2, 1994 
Accepted December 6, 1994 
